Company profile for The Gamaleya National Center of Epidemiology and Microbiology

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

The Gamaleya National Center of Epidemiology and Microbiology is the world’s leading research institution. The center was founded in 1891 as a private laboratory. Since 1949 it bears the name of Nikolai Gamaleya, a pioneer in Russian microbiology studies. Gamaleya studied at the laboratory of French biologist Louis Pasteur in Paris and opened the world’s second vaccination station for rabies in Russia in 1886. In the 20th...
The Gamaleya National Center of Epidemiology and Microbiology is the world’s leading research institution. The center was founded in 1891 as a private laboratory. Since 1949 it bears the name of Nikolai Gamaleya, a pioneer in Russian microbiology studies. Gamaleya studied at the laboratory of French biologist Louis Pasteur in Paris and opened the world’s second vaccination station for rabies in Russia in 1886. In the 20th century, Gamaleya as one of the heads of the center fought epidemics of cholera, diphtheria and typhus and organized mass vaccination campaigns in the Soviet Union.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Russia
Address
Address
123098, Moscow, Gamaleya street, house 18
Telephone
Telephone
+7 (499) 193-30-01
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Cosmoprof

Cosmoprof

Not Confirmed

envelop Contact Supplier

Cosmoprof

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.clinicaltrialsarena.com/news/russia-sputnik-vaccine-omicron/

CLINICALTRIALSARENA
20 Dec 2021

https://www.reuters.com/article/us-health-coronavirus-philippines-gamale/russias-gamaleya-applies-for-emergency-vaccine-use-in-philippines-idUSKBN29D34R

Neil Jerome Morales REUTERS
11 Jan 2021

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty